TuHURA Biosciences HURA
NASDAQ HURA
$2.18 +0.17 (+8.46%)
At close: Oct 23, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Amortization of Deferred Charges (2020 - 2026)

Updated

Analysis

TuHURA Biosciences (HURA) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 TuHURA Biosciences 138.83 Mn 125.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 295,290.00
Mar 31, 2024 17,383.00
Jun 30, 2021 20,000.00
Mar 31, 2021 23,000.00
Dec 31, 2020 24,000.00
Sep 30, 2020 27,000.00
API Access

TuHURA Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=HURA&period=max&api_key=YOUR_API_KEY